Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 403

1.

[Roles of miR-590-5p and miR-590-3p in the development of hepatocellular carcinoma].

Yang H, Zheng W, Zhao W, Guan C, An J.

Nan Fang Yi Ke Da Xue Xue Bao. 2013 Jun;33(6):804-11. Chinese.

2.

Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.

Li WF, Dai H, Ou Q, Zuo GQ, Liu CA.

Tumour Biol. 2016 May;37(5):5885-95. doi: 10.1007/s13277-015-4456-1. Epub 2015 Nov 21.

PMID:
26589417
3.

miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10.

Xiao ZD, Jiao CY, Huang HT, He LJ, Zhao JJ, Lu ZY, Liu LX.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):4039-44. eCollection 2014.

4.

Down-regulated miR-28-5p in human hepatocellular carcinoma correlated with tumor proliferation and migration by targeting insulin-like growth factor-1 (IGF-1).

Shi X, Teng F.

Mol Cell Biochem. 2015 Oct;408(1-2):283-93. doi: 10.1007/s11010-015-2506-z. Epub 2015 Jul 10.

PMID:
26160280
5.

MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.

Huang GH, Shan H, Li D, Zhou B, Pang PF.

Cell Biochem Funct. 2017 Mar;35(2):98-104. doi: 10.1002/cbf.3252. Epub 2017 Mar 5.

PMID:
28261837
6.

Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN, GalNT7 and vimentin in different signal pathways.

Shan SW, Fang L, Shatseva T, Rutnam ZJ, Yang X, Du W, Lu WY, Xuan JW, Deng Z, Yang BB.

J Cell Sci. 2013 Mar 15;126(Pt 6):1517-30. doi: 10.1242/jcs.122895. Epub 2013 Feb 15.

7.

Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.

Fang L, Sun J, Pan Z, Song Y, Zhong L, Zhang Y, Liu Y, Zheng X, Huang P.

Am J Physiol Gastrointest Liver Physiol. 2017 Aug 1;313(2):G150-G156. doi: 10.1152/ajpgi.00426.2016. Epub 2017 May 19.

PMID:
28526689
8.

MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.

Zhao G, Wang T, Huang QK, Pu M, Sun W, Zhang ZC, Ling R, Tao KS.

World J Gastroenterol. 2016 Jun 21;22(23):5364-73. doi: 10.3748/wjg.v22.i23.5364.

9.

Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.

Shen Q, Cicinnati VR, Zhang X, Iacob S, Weber F, Sotiropoulos GC, Radtke A, Lu M, Paul A, Gerken G, Beckebaum S.

Mol Cancer. 2010 Aug 27;9:227. doi: 10.1186/1476-4598-9-227.

10.

MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.

Long J, Jiang C, Liu B, Fang S, Kuang M.

Tumour Biol. 2016 May;37(5):5821-8. doi: 10.1007/s13277-015-4427-6. Epub 2015 Nov 18.

PMID:
26581909
11.

Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma.

Wang W, Zhao LJ, Tan YX, Ren H, Qi ZT.

World J Gastroenterol. 2012 Oct 14;18(38):5442-53. doi: 10.3748/wjg.v18.i38.5442.

12.

Increased expression of microRNA-31-5p inhibits cell proliferation, migration, and invasion via regulating Sp1 transcription factor in HepG2 hepatocellular carcinoma cell line.

Zhao G, Han C, Zhang Z, Wang L, Xu J.

Biochem Biophys Res Commun. 2017 Aug 19;490(2):371-377. doi: 10.1016/j.bbrc.2017.06.050. Epub 2017 Jun 13.

13.

MiR-30a-5p suppresses cell growth and enhances apoptosis of hepatocellular carcinoma cells via targeting AEG-1.

He R, Yang L, Lin X, Chen X, Lin X, Wei F, Liang X, Luo Y, Wu Y, Gan T, Dang Y, Chen G.

Int J Clin Exp Pathol. 2015 Dec 1;8(12):15632-41. eCollection 2015.

14.

MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.

Fang F, Chang RM, Yu L, Lei X, Xiao S, Yang H, Yang LY.

J Hepatol. 2015 Oct;63(4):874-85. doi: 10.1016/j.jhep.2015.05.008. Epub 2015 May 18.

PMID:
25998163
15.

MicroRNA-361-5p Inhibits Cancer Cell Growth by Targeting CXCR6 in Hepatocellular Carcinoma.

Sun JJ, Chen GY, Xie ZT.

Cell Physiol Biochem. 2016;38(2):777-85. doi: 10.1159/000443033. Epub 2016 Feb 15.

16.

Growth inhibition of hepatocellular carcinoma tumor endothelial cells by miR-204-3p and underlying mechanism.

Cui ZH, Shen SQ, Chen ZB, Hu C.

World J Gastroenterol. 2014 May 14;20(18):5493-504. doi: 10.3748/wjg.v20.i18.5493.

17.

Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.

Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H.

Oncotarget. 2015 Nov 10;6(35):38093-106. doi: 10.18632/oncotarget.5642.

18.

miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.

Zhao L, Zhang Y.

Biochem Biophys Res Commun. 2015 Feb 13;457(3):370-7. doi: 10.1016/j.bbrc.2014.12.119. Epub 2015 Jan 9.

PMID:
25580008
19.

MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.

Huang XP, Hou J, Shen XY, Huang CY, Zhang XH, Xie YA, Luo XL.

FEBS J. 2015 Feb;282(3):579-94. doi: 10.1111/febs.13167. Epub 2014 Dec 27.

20.

Involvement of miR-485-5p in hepatocellular carcinoma progression targeting EMMPRIN.

Sun X, Liu Y, Li M, Wang M, Wang Y.

Biomed Pharmacother. 2015 May;72:58-65. doi: 10.1016/j.biopha.2015.04.008. Epub 2015 Apr 14.

PMID:
26054676

Supplemental Content

Support Center